Skip to content

Clinical trials

Observational Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Clear all

1,428 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20016
200210
200317
200418
200527
200628
200727
200838
200936
201044
201141
201259
201348
201446
201551
201659
201761
201869
201970
202092
202190
202278
2023105
202496
2025107
202670

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed582
Unknown status308
Recruiting275
Not yet recruiting76
Terminated68
Active, not recruiting66
Withdrawn34
Enrolling by invitation15
Suspended4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center35
National Cancer Institute (NCI)30
AstraZeneca29
Memorial Sloan Kettering Cancer Center28
National Taiwan University Hospital24
Mayo Clinic21
Peking University People's Hospital19
Alliance for Clinical Trials in Oncology16
University Health Network, Toronto16
Shanghai Pulmonary Hospital, Shanghai, China15

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms1,428
Carcinoma, Non-Small-Cell Lung288
Breast Neoplasms157
Neoplasms113
Colorectal Neoplasms77
Prostatic Neoplasms73
Head and Neck Neoplasms63
Pancreatic Neoplasms63
Small Cell Lung Carcinoma60
Disease58

Trials

Showing 1 to 25 of 1,428. Each trial links to its page on Pharma Observatory.

1,328 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.